CLS Holdings USA (XCNQ:CLSH) EBITDA Margin % : -71.23% (As of Feb. 2024)

CLS Holdings USA EBITDA Margin % Chart

CLS Holdings USA Annual Data
	Trend	May14	May15	May16	May17	May18	May19	May20	May21	May22	May23
EBITDA Margin %		Get a 7-Day Free Trial					-270.52	-228.80	-46.95	11.05	-38.92

CLS Holdings USA Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EBITDA Margin %	Get a 7-Day Free Trial															6.88	-48.95	12.52	-5.18	-71.23

Competitive Comparison of CLS Holdings USA's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CLS Holdings USA's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's EBITDA Margin % falls into.

CLS Holdings USA EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

CLS Holdings USA's EBITDA Margin % for the fiscal year that ended in May. 2023 is calculated as

CLS Holdings USA's EBITDA Margin % for the quarter that ended in Feb. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CLS Holdings USA  (XCNQ:CLSH) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

CLS Holdings USA EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

CLS Holdings USA (XCNQ:CLSH) Business Description